Cognitive Functions and Intelligence Quotient in Patients with Metabolic Syndrome Through the Window of Type 2 Diabetes Mellitus

Purpose: To evaluate the cognitive functions and intelligence quotient (IQ) in patients with metabolic syndrome (MetS) by also considering Type 2 diabetes mellitus (DM). Materials and Methods: A cross‑sectional study was conducted from January to March 2020. Participants in this study are from a t...

Full description

Bibliographic Details
Main Authors: Ulaş Serkan TOPALOĞLU, Kamil DEVECİ, Mehmet Fatih GÖL, Melih KIZILTEPE, Ersin ULUSOY, Döndü Melek ULUSOY, Bedriye SİMİTCİ
Format: Article
Language:English
Published: Kirsehir Ahi Evran University 2022-04-01
Series:Ahi Evran Medical Journal
Subjects:
Online Access:https://dergipark.org.tr/tr/download/article-file/1529926
_version_ 1797910419293077504
author Ulaş Serkan TOPALOĞLU
Kamil DEVECİ
Mehmet Fatih GÖL
Melih KIZILTEPE
Ersin ULUSOY
Döndü Melek ULUSOY
Bedriye SİMİTCİ
author_facet Ulaş Serkan TOPALOĞLU
Kamil DEVECİ
Mehmet Fatih GÖL
Melih KIZILTEPE
Ersin ULUSOY
Döndü Melek ULUSOY
Bedriye SİMİTCİ
author_sort Ulaş Serkan TOPALOĞLU
collection DOAJ
description Purpose: To evaluate the cognitive functions and intelligence quotient (IQ) in patients with metabolic syndrome (MetS) by also considering Type 2 diabetes mellitus (DM). Materials and Methods: A cross‑sectional study was conducted from January to March 2020. Participants in this study are from a tertiary care hospital. Patients admitted to the outpatient clinic with health check-up, or follow-up of DM were included in the study. A total of 80 patients (44 patients with MetS and 36 patients without MetS), 18-75 years old, were recruited to the study consecutively. Clinical and laboratory parameters, Mini Mental State Examination (MMSE) and Kent E-G-Y scores of patients were measured. Results: Glycated hemoglobin (HbA1c) and triglycerides levels were higher, whereas high-density lipoprotein-cholesterol (HDL-c) and ferritin levels were lower in patients with MetS. MMSE score was lower in participants with MetS than without MetS, whereas Kent E-G-Y score was similar in both groups. Depending on whether all patients have DM and/or MetS, subgroup analyzes were performed and evaluated. Patients with diabetes had lower IQ scores compared to the other subgroups. Conclusion: MetS reduces cognitive functions, whereas it has been shown that this generally does not have any effect on IQ. However, even though DM presence has been shown to be a worsening factor on intelligence in MetS, further studies are needed.
first_indexed 2024-04-10T11:25:06Z
format Article
id doaj.art-055c06c31ff94c2eb17bbfabaf272d68
institution Directory Open Access Journal
issn 2619-9203
language English
last_indexed 2024-04-10T11:25:06Z
publishDate 2022-04-01
publisher Kirsehir Ahi Evran University
record_format Article
series Ahi Evran Medical Journal
spelling doaj.art-055c06c31ff94c2eb17bbfabaf272d682023-02-15T16:18:27ZengKirsehir Ahi Evran UniversityAhi Evran Medical Journal2619-92032022-04-016116https://doi.org/10.46332/aemj.867330Cognitive Functions and Intelligence Quotient in Patients with Metabolic Syndrome Through the Window of Type 2 Diabetes MellitusUlaş Serkan TOPALOĞLU 0https://orcid.org/0000-0001-6625-7763Kamil DEVECİ1https://orcid.org/0000-0002-9108-4769Mehmet Fatih GÖL2https://orcid.org/0000-0001-7773-641XMelih KIZILTEPE3https://orcid.org/0000-0001-6100-2024Ersin ULUSOY4https://orcid.org/0000-0001-7003-4597Döndü Melek ULUSOY 5https://orcid.org/0000-0001-7847-9048Bedriye SİMİTCİ6https://orcid.org/0000-0003-3906-3917Kayseri City HospitalKayseri City HospitalKayseri City HospitalKayseri City HospitalKayseri City HospitalKayseri City HospitalKayseri City HospitalPurpose: To evaluate the cognitive functions and intelligence quotient (IQ) in patients with metabolic syndrome (MetS) by also considering Type 2 diabetes mellitus (DM). Materials and Methods: A cross‑sectional study was conducted from January to March 2020. Participants in this study are from a tertiary care hospital. Patients admitted to the outpatient clinic with health check-up, or follow-up of DM were included in the study. A total of 80 patients (44 patients with MetS and 36 patients without MetS), 18-75 years old, were recruited to the study consecutively. Clinical and laboratory parameters, Mini Mental State Examination (MMSE) and Kent E-G-Y scores of patients were measured. Results: Glycated hemoglobin (HbA1c) and triglycerides levels were higher, whereas high-density lipoprotein-cholesterol (HDL-c) and ferritin levels were lower in patients with MetS. MMSE score was lower in participants with MetS than without MetS, whereas Kent E-G-Y score was similar in both groups. Depending on whether all patients have DM and/or MetS, subgroup analyzes were performed and evaluated. Patients with diabetes had lower IQ scores compared to the other subgroups. Conclusion: MetS reduces cognitive functions, whereas it has been shown that this generally does not have any effect on IQ. However, even though DM presence has been shown to be a worsening factor on intelligence in MetS, further studies are needed.https://dergipark.org.tr/tr/download/article-file/1529926cognitive functiondiabetes mellitusintelligence quotientmetabolic syndrome
spellingShingle Ulaş Serkan TOPALOĞLU
Kamil DEVECİ
Mehmet Fatih GÖL
Melih KIZILTEPE
Ersin ULUSOY
Döndü Melek ULUSOY
Bedriye SİMİTCİ
Cognitive Functions and Intelligence Quotient in Patients with Metabolic Syndrome Through the Window of Type 2 Diabetes Mellitus
Ahi Evran Medical Journal
cognitive function
diabetes mellitus
intelligence quotient
metabolic syndrome
title Cognitive Functions and Intelligence Quotient in Patients with Metabolic Syndrome Through the Window of Type 2 Diabetes Mellitus
title_full Cognitive Functions and Intelligence Quotient in Patients with Metabolic Syndrome Through the Window of Type 2 Diabetes Mellitus
title_fullStr Cognitive Functions and Intelligence Quotient in Patients with Metabolic Syndrome Through the Window of Type 2 Diabetes Mellitus
title_full_unstemmed Cognitive Functions and Intelligence Quotient in Patients with Metabolic Syndrome Through the Window of Type 2 Diabetes Mellitus
title_short Cognitive Functions and Intelligence Quotient in Patients with Metabolic Syndrome Through the Window of Type 2 Diabetes Mellitus
title_sort cognitive functions and intelligence quotient in patients with metabolic syndrome through the window of type 2 diabetes mellitus
topic cognitive function
diabetes mellitus
intelligence quotient
metabolic syndrome
url https://dergipark.org.tr/tr/download/article-file/1529926
work_keys_str_mv AT ulasserkantopaloglu cognitivefunctionsandintelligencequotientinpatientswithmetabolicsyndromethroughthewindowoftype2diabetesmellitus
AT kamildeveci cognitivefunctionsandintelligencequotientinpatientswithmetabolicsyndromethroughthewindowoftype2diabetesmellitus
AT mehmetfatihgol cognitivefunctionsandintelligencequotientinpatientswithmetabolicsyndromethroughthewindowoftype2diabetesmellitus
AT melihkiziltepe cognitivefunctionsandintelligencequotientinpatientswithmetabolicsyndromethroughthewindowoftype2diabetesmellitus
AT ersinulusoy cognitivefunctionsandintelligencequotientinpatientswithmetabolicsyndromethroughthewindowoftype2diabetesmellitus
AT dondumelekulusoy cognitivefunctionsandintelligencequotientinpatientswithmetabolicsyndromethroughthewindowoftype2diabetesmellitus
AT bedriyesimitci cognitivefunctionsandintelligencequotientinpatientswithmetabolicsyndromethroughthewindowoftype2diabetesmellitus